Medical devices, healthcare technology and the business of care
PMA approval · P130008

INSPIRE II UPPER AIRWAY STIMULATOR

Inspire Medical Systems · Decision date Apr 30, 2014

FDA DECISIONP130008

What did the FDA approve?

FDA records P130008 as an original PMA application. The recorded decision is approval, dated Apr 30, 2014.

FDA approval order statement

APPROVAL FOR THE INSPIRE UPPER AIRWAY STIMULATION (UAS) SYSTEM, WHICH INCLUDES THE MODEL 3024 IMPLANTABLE PULSE GENERATOR, THE MODEL 4063 STIMULATION LEAD, THE MODEL 4323 SENSING LEAD, THE MODEL 2740PHYSICIAN PROGRAMMER, AND THE MODEL 3032 PATIENT PROGRAMMER. THE DEVICE IS USED TO TREAT A SUBSET OF PATIENTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA (OSA) (APNEA-HYPOPNEA INDEX [AHI] OF GREATER OR EQUAL TO 20 AND LESS THAN OR EQUAL TO 65). INSPIRE UAS IS USED IN ADULT PATIENTS 22 YEARS OF AGE AND OLDER WHO HAVE BEEN CONFIRMED TO FAIL OR CANNOT TOLERATE POSITIVE AIRWAY PRESSURE (PAP) TREATMENTS (SUCH AS CONTINUOUS POSITIVE AIRWAY PRESSURE [CPAP] OR BILEVEL POSITIVE AIRWAY PRESSURE [BPAP] MACHINES) AND WHO DO NOT HAVE A COMPLETE CONCENTRIC COLLAPSE AT THE SOFT PALATE LEVEL. PAP FAILURE IS DEFINED AS AN INABILITY TO ELIMINATE OSA (AHI OF GREATER THAN 20 DESPITE PAP USAGE) AND PAP INTOLERANCE IS DEFINED AS: 1) INABILITY TO USE PAP (GREATER THAN 5 NIGHTS PER WEEK OF USAGE; USAGE DEFINED AS GREATER THAN 4 HOURS OF USE PER NIGHT); OR 2) UNWILLINGNESS TO USE PAP (FOR EXAMPLE, A PATIENT RETURNS THE PAP SYSTEM AFTER ATTEMPTING TO USE IT).
Regulatory pathway
Original PMA
Clinical specialty
Anesthesiology
Decision date
Apr 30, 2014

FDA source record

Regulatory record facts

Identifier
P130008
Regulatory pathway
Premarket approval application
Product code
MNQ
Decision code
APPR
Decision date
Apr 30, 2014
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.

Product code
MNQ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P130008 received

    Application receipt date recorded by FDA.

  2. P130008 · FDA decision

    APPR

  3. P130008/S144 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  4. P130008/S148 · Related supplement

    Model 4063 Dedicated Tray Sealer

Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130008

Product / regulatory recordCompanyPathwayDecision dateSource
Model 3150 IPGP130008/S146
Inspire Medical SystemsPMA supplementOct 13, 2026FDA
Model 3150 IPGP130008/S147
Inspire Medical SystemsPMA supplementOct 22, 2026FDA
Inspire Medical SystemsPMA supplementOct 26, 2026FDA
Inspire Medical SystemsPMA supplementNov 5, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inspire Medical Systems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records